PSA Test: Reconsidering the Recommendation

The prostate cancer screening test called PSA, which checks levels of the protein prostate-specific antigen, has a history checkered with controversy. The test can save lives, yet it has been long-known not to be perfect. For starters, there are an uncomfortable number of screening tests that turn out to be false positives, which leads to…

PSA: The Prostate Cancer Screening Test

Prostate cancer is the second most common cancer in American men, following skin cancer. One in every seven men will be diagnosed with this form of cancer in his lifetime; with the average age of diagnosis being age 66. In terms of fatalities, only lung cancer comes with a higher mortality rate. Prostate cancer is…

Cancer: Cure Vs. Control

Not every form of cancer can be cured. Sometimes the best outcome is living with cancer as a chronic condition, as one might with diabetes or heart disease. Controlling – rather than curing – cancer is more likely to be the appropriate course of action with these cancers: ovarian, chronic leukemia, some lymphomas, and metastatic…

Leukemia Drug Could Also Help Skin, Breast, and Other Cancers

Kimberly M. Hicks, Pharm.D., M.H.A., Clinical Pharmacy Specialist at BioPlus Specialty Pharmacy A well-known medication used for a specific type of leukemia now shows promise against several other cancers. This chemotherapy tablet, Sprycel® (dasatinib) from Bristol-Myers Squibb, gained FDA approval for treating chronic myelogenous leukemia in 2010, although it had been approved since 2006 in…

Better Cancer Screening Tests

Kimberly M. Hicks, Pharm.D., M.H.A., Clinical Pharmacy Specialist at BioPlus Specialty Pharmacy Screening tests are well-known and regularly used for several cancers, including breast cancer and cervical cancer; however, there are many other cancer sites that lack an effective early detection tool. That could soon be changing for lung cancer and prostate cancer. Lung cancer…